142 related articles for article (PubMed ID: 16287250)
1. SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn.
Kircheis R; Vondru P; Nechansky A; Ohler R; Loibner H; Himmler G; Mudde GC
Bioconjug Chem; 2005; 16(6):1519-28. PubMed ID: 16287250
[TBL] [Abstract][Full Text] [Related]
2. Immunization of Rhesus monkeys with the conjugate vaccine IGN402 induces an IgG immune response against carbohydrate and protein antigens, and cancer cells.
Kircheis R; Vondru P; Zinöcker I; Häring D; Nechansky A; Loibner H; Mudde GC
Vaccine; 2006 Mar; 24(13):2349-57. PubMed ID: 16406172
[TBL] [Abstract][Full Text] [Related]
3. Immunization of Rhesus monkeys with a SialylTn-mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cells.
Kircheis R; Siegl P; Grunt S; Halanek N; Loibner H; Mudde GC; Nechansky A
Cancer Immunol Immunother; 2007 Jun; 56(6):863-73. PubMed ID: 17009044
[TBL] [Abstract][Full Text] [Related]
4. Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
O'Boyle KP; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd KO; Oettgen HF; Old LJ; Livingston PO
Cancer Res; 1992 Oct; 52(20):5663-7. PubMed ID: 1394190
[TBL] [Abstract][Full Text] [Related]
5. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.
Gilewski TA; Ragupathi G; Dickler M; Powell S; Bhuta S; Panageas K; Koganty RR; Chin-Eng J; Hudis C; Norton L; Houghton AN; Livingston PO
Clin Cancer Res; 2007 May; 13(10):2977-85. PubMed ID: 17504999
[TBL] [Abstract][Full Text] [Related]
6. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
Lo-Man R; Bay S; Vichier-Guerre S; Dériaud E; Cantacuzène D; Leclerc C
Cancer Res; 1999 Apr; 59(7):1520-4. PubMed ID: 10197623
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.
Kieber-Emmons T; Luo P; Qiu J; Chang TY; O I; Blaszczyk-Thurin M; Steplewski Z
Nat Biotechnol; 1999 Jul; 17(7):660-5. PubMed ID: 10404158
[TBL] [Abstract][Full Text] [Related]
8. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.
Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C
Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473
[TBL] [Abstract][Full Text] [Related]
9. Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.
Ouerfelli O; Warren JD; Wilson RM; Danishefsky SJ
Expert Rev Vaccines; 2005 Oct; 4(5):677-85. PubMed ID: 16221069
[TBL] [Abstract][Full Text] [Related]
10. Effects of desialylation of ovine submaxillary gland mucin (OSM) on humoral and cellular immune responses to Tn and sialylated Tn.
O'Boyle KP; Coatsworth S; Anthony G; Ramirez M; Greenwald E; Kaleya R; Steinberg JJ; Dutcher JP; Wiernik PH
Cancer Immun; 2006 Mar; 6():5. PubMed ID: 16524255
[TBL] [Abstract][Full Text] [Related]
11. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
[TBL] [Abstract][Full Text] [Related]
12. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.
Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T
Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414
[TBL] [Abstract][Full Text] [Related]
13. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
Horwacik I
Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
[TBL] [Abstract][Full Text] [Related]
14. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
16. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
Longenecker BM; Reddish M; Koganty R; MacLean GD
Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
[TBL] [Abstract][Full Text] [Related]
17. [Recent advance in carbohydrate-based cancer vaccines].
Huo CX; Ye XS
Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
[TBL] [Abstract][Full Text] [Related]
18. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
Sadoulet MO; Franceschi C; Aubert M; Silvy F; Bernard JP; Lombardo D; Mas E
Glycobiology; 2007 Jun; 17(6):620-30. PubMed ID: 17374617
[TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
20. Assessing vaccine potency using TCRmimic antibodies.
Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
